Scarica l'app Stockscreener
7.28
2.41%
-0.20
Acurx Pharmaceuticals Inc Azioni (ACXP) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
5.61%
2.2697
|
2.1492 | 2.7818 | 2.8216 | 4.1218 |
| Operating Income/Loss |
4.28%
-2.2697
|
-2.1765 | - | - | - |
| Income/Loss From Continuing Operations Before Tax |
4.52%
-2.2463
|
-2.1492 | -2.7818 | -2.8216 | -4.1218 |
| Income/Loss From Continuing Operations After Tax |
4.52%
-2.2463
|
-2.1492 | -2.7818 | -2.8216 | -4.1218 |
|
Net Income/Loss
|
4.52%
-2.2463
|
-2.1492 | -2.7818 | -2.8216 | -4.1218 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
94.06%
1.1903
|
20.04 | 0.2556 | 16.36 | 15.82 |
| Diluted Average Shares |
94.06%
1.1903
|
20.04 | 0.2556 | 16.36 | 15.82 |
| Basic Earnings Per Share |
1,618%
-1.89
|
-0.11 | -0.16 | -0.17 | -0.26 |
| Diluted Earnings Per Share |
1,618%
-1.89
|
-0.11 | -0.16 | -0.17 | -0.26 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):